Dialysis Instrumentation Market worth $83.21 Billion by 2018

The report “Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] – Global Forecast to 2018”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and Rest of the World.

http://www.marketsandmarkets.com/Market-Reports/dialysis-market-1279.html

The global market is valued at $61.60 billion in 2013 and is expected to reach $83.20 billion by 2018, at a CAGR of 6.2% from 2013 to 2018.

In the report, the market has been segmented into hemodialysis and peritoneal products and services. The Hemodialysis products and services segment held the largest share of 85% in the global market, in 2012. Furthermore, the market has also been segmented on the basis of category (hemodialysis and peritoneal dialysis) and end-users (in-center dialysis and home dialysis). Inclination of patients towards home hemodialysis and nocturnal hemodialysis treatments exhibits a high growth potential for industry players in the near future.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=1279

North America holds the largest share of the global market. However, in the forthcoming years, developing regions such as Asia-Pacific (Japan, China, South Korea, and India), Latin America, and the Middle East are expected to form new revenue generating pockets for the market players. Economic developments, the presence of a large patient population, the growing number of dialysis centers, rising incidence and prevalence of diabetes and hypertension, and increasing government initiatives to develop/improve dialysis care are the key factors that drives the growth of the market in developing regions.

Enquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1279

The market is majorly dominated by a few players such as Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners Inc. (U.S.), Gambro AB (Sweden), Baxter International Inc. (U.S.), and B. Braun Melsungen AG (Germany). Fresenius Medical Care holds the leading position in the market with a share of ~24% in 2013. Partnerships and collaborations are the key strategies adopted by market players to ensure their growth in the market. The introduction of the bundle reimbursement system has further lead to an increase in the number of collaborative partnerships among industry participants.